Please login to the form below
Relvar
This page shows the latest Relvar news and features for those working in and with pharma, biotech and healthcare.
GSK's Witty ends on a high, but warns 2017 looking 'uncertain'
At the moment, new respiratory products such as Relvar/Breo (fluticasone furoate/vilanterol) are covering the decline in Advair, which fell 20% to £975m ($1.2bn) in the fourth quarter of
Latest news
-
GSK files first application for triple COPD therapy
protect its franchise with the launch of new two-drug combinations such as Relvar/Breo (vilanterol/fluticasone furoate) and Anoro (vilanterol/umeclidinium bromide).
-
New drugs breathe life into GSK's respiratory business
New asthma and COPD drugs such as Relvar/Breo (vilanterol/fluticasone furoate) and Anoro (vilanterol/umeclidinium bromide) added £243m ($319m) in the quarter, more than offsetting a 13% decline in Seretide
-
GSK's triple COPD therapy tops Symbicort in phase III trial
These include GSK's Relvar/Breo (vilanterol/fluticasone furoate) and Anoro (vilanterol/umeclidinium bromide), as well as Novartis' Ultibro (glycopyrronium/indacaterol), AZ's own Duaklir (aclidinium bromide/formoterol fumarate) and Boehringer
-
GSK brings forward triple COPD therapy filing in US
The company suffered declining respiratory sales through 2015 - although its performance improved in the first quarter of this year thanks to gathering momentum for two-drug combinations Relvar/Breo (vilanterol/fluticasone
-
Respiratory return helps GSK to solid first quarter
Relvar/Breo (vilanterol/fluticasone furoate), Anoro (vilanterol/umeclidinium bromide) and severe asthma debutante Nucala (mepolizumab).
More from news
Approximately 3 fully matching, plus 29 partially matching documents found.
Featured jobs
- Scientific Director, Medical Communications
-
£60 – 70, 000 benefits
- Account Director, Healthcare Communications
-
£50, 000 - £60, 000
-
Account Director at PAREXEL MedCom
-
Competitive Salary
-
Editorial Director - BioScience
-
Competitive Salary
- Digital Account Director – Healthcare Communications
-
£50 – 60, 000 benefits
-
Account Director
-
Salary TBC
- Scientific Team Leader, Medical Education
-
£55, 000 – £70, 000 benefits
-
Medical Editor
-
Great salary and benefits
-
Principal Medical Writer
-
Great salary and benefits
Subscribe to our email news alerts
PMHub
GEM Marketing Ltd
GEM, a small but perfectly formed integrated marketing agency servicing the pharmaceutical industry....
Latest intelligence
- Tools for the digital world
- The next step for the pharma industry...
- How Can We Make Payer Communications Really Sing?
- With so many different influences at play in access decisions, how can we make sure we tap into what’s really driving payer decision-making. How do we go beyond the stated...
- Harnessing the power of core elements to optimise market access
- This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...
Quick links
Infographics
